|
|
Article: "Three Shots and They're Out" - Allergy Immunotherapy Study Sheds New Light on When Patients Stop Treatment.(Report)
- Article from:
- Business Wire
- Article date:
- March 17, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON -- New research presented at the 2009 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI), highlighted poor compliance among allergy immunotherapy candidates. The research project, supported by Greer, was conducted by Allergy Partners, P.A., a large, single-specialty allergy practice, and is the first to evaluate patterns of allergy immunotherapy care in a "real world" allergy practice setting.
The goal of the study was to evaluate patterns of care among patients who received allergy testing and subsequent allergy immunotherapy, commonly known as allergy shots. The study also sought to identify aspects of compliance with allergy ...